U.S. pharma big copyright scrapped two experimental weight loss capsules past 12 months—a after-everyday capsule, lotiglipron, because of elevated liver enzymes and also a 2 times-day-to-day pill, danuglipron, due to robust Negative effects—but CEO Albert Bourla has explained the company is set to “Enjoy and get” during the weight problems